Topic Highlight
Copyright ©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastrointest Oncol. Dec 15, 2013; 5(12): 222-229
Published online Dec 15, 2013. doi: 10.4251/wjgo.v5.i12.222
Pneumo-CT assessing response to neoadjuvant therapy in esophageal cancer: Imaging-pathological correlation
Marina Ulla, Ernestina Gentile, Ezequiel Levy Yeyati, Maria L Diez, Demetrio Cavadas, Ricardo D Garcia-Monaco, Pablo R Ros
Marina Ulla, Ernestina Gentile, Ezequiel Levy Yeyati, Maria L Diez, Demetrio Cavadas, Ricardo D Garcia-Monaco, Pablo R Ros, Department of Radiology, Hospital Italiano de Buenos Aires, Gascón 450, Argentina
Author contributions: All authors designed the research; Ulla M and Diez ML performed the research; Gentile E and Levy Yeyati E contributed new reagents/analytic tools; Ulla M and Ros PR wrote the paper.
Correspondence to: Marina Ulla, MD, CT Medical Chief, Professor of Medicine, Department of Radiology, Hospital Italiano de Buenos Aires, Peron 4190, Gascón 450,Argentina. ulla@hospitalitaliano.org.ar
Telephone: +54-11-49590453 Fax: +54-11-49590453
Received: August 22, 2013
Revised: September 22, 2013
Accepted: October 11, 2013
Published online: December 15, 2013
Processing time: 116 Days and 11.6 Hours
Core Tip

Core tip: Pneumo-computed tomography may be a useful technique to monitor neoadjuvant therapy response as it enhances morphologic details. Besides, it provides key information for surgical planning as it helps to define both upper and lower borders of esophageal or gastro-esophageal neoplasms in a single examination.